Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125981002 | 12598100 | 2 | F | 20160719 | 20160726 | 20160729 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-48105NB | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160729 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125981002 | 12598100 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Oral | 40 MG | U | 20850 | 40 | MG | TABLET | QD | |||||
| 125981002 | 12598100 | 2 | SS | MICARDIS | TELMISARTAN | 1 | Oral | 20 MG | U | 20850 | 20 | MG | TABLET | QD | |||||
| 125981002 | 12598100 | 3 | SS | MICARDIS | TELMISARTAN | 1 | Oral | 40 MG | U | 20850 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125981002 | 12598100 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125981002 | 12598100 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125981002 | 12598100 | Blood pressure increased | |
| 125981002 | 12598100 | Palpitations | |
| 125981002 | 12598100 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |